| %/Mean (SD) | Number estimated (%) |
---|---|---|
Age (years) | 65 (11) | 338 (100) |
Men | 64 | 338 (100) |
Duration of diabetes mellitus (years) | 11 (10) | 254 (75) |
Current plus past smoking | 57 | 282 (83) |
Current drinker | 43 | 268 (79) |
Therapeutic method for diabetes mellitus | Â | 338 (100) |
   Diet only/OHA/Insulin | 4/51/44 |  |
Body mass index (kg/m2) | 24.4 (4.4) | 333 (99) |
Obesity# | 36 | 333 (99) |
Hypertension | 78 | 338 (100) |
Systolic blood pressure (mmHg) | 132 (19) | 338 (100) |
Diastolic blood pressure (mmHg) | 76 (12) | 338 (100) |
Antihypertensive agents | Â | 338 (100) |
   ACEi | 19 |  |
   ARB | 46 |  |
   CCB | 48 |  |
Hyperlipidaemia | 73 | 338 (100) |
   Statin | 54 |  |
HbA1c (%) | 7.2 (1.7) | 316 (94) |
Total cholesterol (mmol/L) | 4.9 (1.1) | 262 (78) |
LDL cholesterol (mmol/L) | 2.9 (1.0) | 297 (88) |
HDL cholesterol (mmol/L) | 1.5 (0.4) | 299 (89) |
Serum creatinine (μmol/L) | 92 (69) | 338 (100) |
Estimated GFR (mL/min/1.73 m2) | 57.5 (21.5) | 338 (100) |
CKD stage | Â | 338 (100) |
   Stage 1 | 5 |  |
   Stage 2 | 45 |  |
   Stage 3 | 39 |  |
   Stage 4+5 | 11 |  |
Diabetic retinopathy$ | 45 | 254 (75) |
Diabetic neuropathy | 84 | 256 (76) |
Cerebrovascular disease | 23 | 336 (99) |
Coronary heart disease | 21 | 337 (100) |
Peripheral arterial disease | 4 | 338 (100) |
Diabetic nephropathy | Â | 321 (95) |
   Stage I | 47 |  |
   Stage II | 25 |  |
   Stage III | 17 |  |
   Stage IV | 11 |  |
ABI | 1.1 (0.1) | 240 (71) |
baPWV (cm/s) | 1794 (397) | 239 (71) |
IMT (mm) | 1.06 (0.27) | 338 (100) |